Whitehawk Therapeutics (WHWK) Assets Average: 2018-2025
Historic Assets Average for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to $173.9 million.
- Whitehawk Therapeutics' Assets Average rose 85.69% to $173.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $173.9 million, marking a year-over-year increase of 85.69%. This contributed to the annual value of $101.4 million for FY2024, which is 35.97% down from last year.
- As of Q3 2025, Whitehawk Therapeutics' Assets Average stood at $173.9 million, which was down 16.15% from $207.4 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Assets Average high stood at $207.4 million for Q2 2025, and its period low was $30.0 million during Q1 2021.
- Its 3-year average for Assets Average is $141.2 million, with a median of $145.4 million in 2023.
- Per our database at Business Quant, Whitehawk Therapeutics' Assets Average surged by 400.50% in 2022 and then crashed by 42.66% in 2024.
- Quarterly analysis of 5 years shows Whitehawk Therapeutics' Assets Average stood at $163.3 million in 2021, then rose by 15.81% to $189.2 million in 2022, then fell by 28.09% to $136.0 million in 2023, then plummeted by 42.66% to $78.0 million in 2024, then soared by 85.69% to $173.9 million in 2025.
- Its Assets Average stands at $173.9 million for Q3 2025, versus $207.4 million for Q2 2025 and $152.2 million for Q1 2025.